`
`AO 120 (Rev 08/JO)
`
`TO:
`
`Mail Stop 8
`Director of the U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`REPORT ON THE
`FILING OR DETERMINATION OF AN
`ACTION REGARDING A PATENT OR
`TRADEMARK
`
`In Compliance with 35 U.S.C. § 290 and/or 15 U.S.C. § 1116 you are hereby advised that a court action has been
`for the District of Delaware
`filed in the U.S. District Court
`on the following
`Glf Patents.
`0 Trademarks or
`( 0 the patent action involves 35 U.S.C. § 292.):
`yocKET 40. '.'>
`15
`4~"\ ~ ·\..P.._
`PLAINTIFF
`
`DATE FILED
`12/2/2014
`
`U.S. DISTRICT COURT
`for the District of Delaware
`
`DEFENDANT
`
`Meda Pharmaceuticals Inc. and Cipla Ltd.
`
`Apotex Inc. and Apotex Corp.
`
`PATENTOR
`TRADEMARK NO.
`
`DATE OF PATENT
`OR TRADEMARK
`
`HOLDER OF PATENT OR TRADEMARK
`
`1 8,163,723
`
`2 8,168,620
`
`4/24/2012
`
`5/1/2012
`
`Cipla Ltd.
`
`Cipla Ltd.
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following patent(s)/ trademark(s) have been included:
`
`DA TE INCLUDED
`
`PATENTOR
`TRADEMARK NO.
`
`INCLUDED BY
`
`0 Amendment
`DATE OF PATENT
`OR TRADEMARK
`
`0 Answer
`
`D Cross Bill
`
`0 Other Pleading
`
`HOLDER OF PA TENT OR TRADEMARK
`
`1
`
`2
`
`3
`
`4
`
`5
`
`In the above-entitled case, the following decision has been rendered or judgement issued:
`
`DECISION/JUDGEMENT
`
`I CLERK
`dohn A. Cerino
`
`I (RY) DEPUTY CLERK
`
`IDATE
`
`1z/11. {a Dl7
`
`Copy 1-Upon initiation of action, mail this copy to Director Copy 3-Upon termination of action, mail this copy to Director
`Copy 2-Upon filing document adding patent(s), mail this copy to Director Copy 4-Case file copy
`
`
`
`Case 1:14-cv-01453-LPS Document 175 Filed 06/16/17 Page 2 of 3 PageID #: 5344
`
`IN THE UNITED STATES DISTRICT COURT
`FOR THE DISTRICT OF DELA WARE
`
`MEDA PHARMACEUTICALS INC. and
`CIPLA LTD.,
`
`Plaintiffs,
`
`v.
`
`APOTEX INC. and APOTEX CORP.,
`
`Defendants.
`
`)
`)
`)
`)
`)
`)
`)
`)
`)
`)
`
`C.A. No. 14-1453-LPS
`
`STIPULATION AND DISMISSAL ORDER
`
`Pursuant to Rule 41(a)(l)(ii) and (c), Fed. R. Civ. P., Meda Pharmaceuticals Inc. and
`
`Cipla Ltd. (collectively, "Plaintiffs") and Apotex Corporation and Apotex Inc. (collectively,
`
`"Defendants") having settled their respective claims and disputes ("Settlement Agreement"),
`
`through their respective counsel, stipulate and agree, subject to the Court's approval, that all
`
`claims and counterclaims in this action are dismissed without prejudice.
`
`Accordingly, pursuant to the above stipulation, and upon the consent and request of
`
`Plaintiffs and Defendants, IT IS HEREBY ORDERED, ADJUDGED, AND DECREED THAT:
`
`1.
`
`All claims, defenses, and counterclaims between Plaintiffs and Defendants are
`
`hereby dismissed without prejudice.
`
`2.
`
`Each party shall bear its own costs, attorneys' fees, and expenses incurred in
`
`connection with the claims and counterclaims dismissed by this Order.
`
`rlfl l 7534016v. l
`
`
`
`Case 1:14-cv-01453-LPS Document 175 Filed 06/16/17 Page 3 of 3 PageID #: 5345
`
`RICHARDS, LAYTON & FINGER, P.A.
`
`Isl Selena E. Molina
`Frederick L. Cottrell, III (#2555)
`Selena E. Molina (#5936)
`920 North King Street,
`Wilmington, DE 19801
`(302) 651-7700
`cottrell@rlf.com
`molina@rlf.com
`
`Attorneys for Plaintiffs
`Meda Pharmaceuticals Inc. and Cipla Ltd.
`
`HEYMAN ENERIO GATTUSO &
`HIRZEL LLP
`
`Isl Dominick T Gattuso
`Dominick T. Gattuso (# 3630)
`300 Delaware Avenue, Suite 200
`Wilmington, DE 19801
`(302) 472-7300
`dgattuso@hegh.law
`
`Attorneys for Defendants Apotex Inc. and
`Apotex Corp.
`
`Dated: May 10, 2017
`
`SO ORDERED THIS \ ) ~y of ""' ~ , 2017.
`
`- - - - - t -
`
`rlfl 17534016v.l
`
`2
`
`